Clinical Trials Browser

Active not recruiting × Digestive System Diseases × Clear all

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT05063565 2026-04-29

ROWAN

Phase 2 Active not recruiting

100 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT03151564 2026-03-05

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

Phase NA Active not recruiting

146 enrolled

Gastrointestinal

Colonic Neoplasms, Digestive System Diseases, Colorectal Neoplasms

NCT03214510 2026-03-05

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

Phase 3 Active not recruiting

101 enrolled

Digestive System Diseases

NCT02156739 2025-12-22

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Phase NA Active not recruiting

100 enrolled

Gastrointestinal

Digestive System Diseases, Carcinoma, Hepatocellular

NCT05874726 2025-12-02

Biological Sample Repository for Gastrointestinal Disorders

Active not recruiting

500 enrolled

GastrointestinalOther

Collagen Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Gastroesophageal Reflux, Hyperlipidemias, Hypertension, Neoplasms, Obesity, Obesity, Morbid, Sleep Apnea Syndromes, Weight Loss, Overweight

NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Phase 3 Active not recruiting

831 enrolled 2 FDA

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT01047735 2025-07-11

TRIABETES

Phase NA Active not recruiting

69 enrolled

Other

Behavior, Blindness, Body Weight, Cardiovascular Diseases, Death, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Disease, Hypertension, Inflammation, Insulin Resistance, Liver Diseases, Motor Activity, Myocardial Infarction, Neoplasms, Obesity, Obesity, Morbid, Weight Loss, Atherosclerosis, Renal Insufficiency, Non-alcoholic Fatty Liver Disease

NCT03464305 2024-03-19

ASPIRIN

Phase 3 Active not recruiting

148 enrolled

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Pathologic Processes, Recurrence, Colorectal Neoplasms, Disease Attributes

NCT05602935 2023-09-28

Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study

Phase 2 Active not recruiting

29 enrolled

Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Stomach Diseases, Stomach Neoplasms

Clinical Trials

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

ROWAN

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Biological Sample Repository for Gastrointestinal Disorders

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

TRIABETES

ASPIRIN

Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study